Extramural Funding
Overall, NCI obligations for its extramural program, which includes grants and contracts, totaled $5.41 billion in fiscal year 2023.
- Obligations for grants totaled approximately 82.8% of extramural funding
- Obligations for contracts totaled approximately 17.2% of extramural funding
Obligations on this page include fiscal year 2023 Cancer Moonshot℠ funding and excludes fiscal years 2022 through 2017 Cures Moonshot carryover obligations.
| Mechanism | Amount | Percent |
|---|---|---|
|
Research & Development (R&D) Contracts |
$899,070,171 |
16.6% |
| Buildings and Facilities | $30,000,000 | 0.6% |
| Construction Contracts | $0 | 0.0% |
| Subtotal Contracts |
$929,070,171 |
17.2% |
| Research Project Grants (RPGs) |
$3,145,236,780 |
58.1% |
|
Cancer Centers/Specialized Centers/SPORES |
$624,438,597 |
11.5% |
| NRSA |
$90,324,558 |
1.7% |
| Other Research Grants |
$621,500,774 |
11.5% |
| Subtotal Grants |
$4,481,500,709 |
82.8% |
| Total Extramural Funds | $5,410,570,880 | 100.0% |
| Intramural/RMS Funds |
$1,776,330,616 |
|
| Total NCI |
$7,186,901,496 |
|